Related Experiment Video
Updated: Aug 5, 2026
Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Effect of Combined Polyphenol on the Disease Course in Children Diagnosed with Influenza
Eren Güzeloğlu1, Vefik Arica1, Belen Ateş1
1Department of Pediatrics, Prof. Dr. Cemil Taşcıoğlu City Hospital, University of Health Sciences, Istanbul 34384, Türkiye.
Insights
This study found that a polyphenol, vitamin D3, vitamin C, and zinc supplement, when given with antiviral therapy, significantly reduced symptom duration and severity in children with influenza. This combination therapy also led to faster recovery and return to normal activities.
Area of Science:
- Pediatric Infectious Diseases
- Nutritional Immunology
- Pharmacology
Background:
- Influenza in children leads to significant symptom burden and functional impairment.
- Antiviral therapy is a standard treatment, but adjunctive therapies are being explored to improve outcomes.
- Nutritional supplements, including polyphenols and vitamins, are investigated for their potential immunomodulatory and antiviral effects.
Purpose of the Study:
- To evaluate the efficacy of a polyphenol, vitamin D3, vitamin C, and zinc preparation as an adjunct to antiviral therapy in pediatric influenza.
- To assess the impact on symptom duration, severity, fever resolution, and functional recovery.
Main Methods:
- Multicenter retrospective real-world data analysis of 128 children (4-10 years) with influenza.
- Comparison between a control group (antiviral therapy alone) and a combined polyphenol group (antiviral therapy + supplement).
- Assessment of symptom scores, fever resolution, and functional outcomes over 7 days.
Main Results:
- The combined polyphenol group showed significantly faster and more marked improvement in all symptom scores by Day 3 and Day 5 compared to the control group.
- Time to fever resolution was significantly shorter in the combined polyphenol group (1.84 days vs. 4.5 days).
- Faster return to school and parental work, reduced need for healthcare visits and antipyretics, and high tolerability were observed in the combined polyphenol group.
Conclusions:
- Adjunctive use of a polyphenol, vitamin D3, vitamin C, and zinc preparation significantly shortened symptom duration and severity in pediatric influenza.
- This combination therapy facilitated faster functional recovery and reduced the need for additional medical interventions.
- The supplement demonstrated a promising, well-tolerated role in managing pediatric influenza alongside standard antiviral treatment.
Abstract:
Objective: This multicenter retrospective real-world data study aimed to evaluate whether the use of a preparation containing polyphenol, vitamin D3, vitamin C, and zinc in addition to antiviral therapy was associated with symptom duration and severity, time to fever resolution, and functional recovery in children diagnosed with influenza. Materials and Methods: This was a five-center, multicenter, retrospective, comparative real-world data analysis. A total of 128 patients aged 4-10 years with a clinical diagnosis of influenza were classified into a control group receiving antiviral therapy alone (n = 64) and a combined polyphenol group receiving, in addition to antiviral therapy, a preparation containing polyphenol, vitamin D3, vitamin C, and zinc (n = 64). Clinical data were obtained from electronic patient records and parent-reported information. Symptom severity (0-3 ordinal score), recovery time, and functional outcomes were assessed on Days 0, 3, 5, and 7. Continuous variables were compared using the independent-samples t test, categorical variables using the chi-square or Fisher exact test, and changes over time using a repeated-measures general linear model. Statistical significance was accepted as a two-sided p value of <0.05. Results: In this study including 128 pediatric patients, there were no significant differences between the combined polyphenol and control groups in demographic or baseline clinical characteristics (p > 0.05). During follow-up, all symptom scores improved more rapidly and markedly in the combined polyphenol group than in the control group. By Day 3, significant differences were observed between groups in fever, cough, rhinorrhea, sore throat, fatigue, general condition, and physical activity scores (p < 0.001 for all parameters). By Day 5, almost complete resolution of symptoms (score 0) was observed in the combined polyphenol group, whereas symptoms persisted to a substantial extent in the control group (p < 0.001). The time to fever resolution was significantly shorter in the combined polyphenol group (1.84 ± 0.72 days vs. 4.5 ± 1.36 days; p < 0.001). Similarly, time to return to school (3.21 ± 0.9 days vs. 5.8 ± 1.91 days; p < 0.001) and time for parents to return to work were significantly shorter in the combined polyphenol group (p < 0.001). The need for additional healthcare visits and antipyretic use was markedly lower in the combined polyphenol group (Day 3: 20.3% vs. 53.1%; Day 5: 0% vs. 15.6%; p < 0.001 for both comparisons). Repeated-measures analyses showed a significant time-by-group interaction, indicating that the reduction in symptom scores occurred more rapidly and prominently in the combined polyphenol group (p < 0.001). Treatment was generally well tolerated in the combined polyphenol group; no serious adverse events were reported, and parent-reported tolerability was high (9.39 ± 0.7). Conclusions: This multicenter retrospective real-world data study suggests that the use of a preparation containing polyphenol, vitamin D3, vitamin C, and zinc in addition to antiviral therapy was associated with shorter symptom duration, lower symptom severity scores, and faster functional recovery in children diagnosed with influenza. These findings suggest that this combination may represent a promising and well-tolerated adjunctive approach in the management of pediatric influenza.